HealthX Ventures — 2022 Investments
4 investments dated 2022 · listed companies and verified rows first · show all
Enso Data provides AI-powered analysis of physiological waveforms, particularly sleep studies, to enable clinical diagnosis and patient monitoring.
AI & Machine LearningDigital HealthHealthtechMedical DevicesMadison, US
Samuel Rusk(Director)Christopher Fernandez(Executive Officer, Director)inSamuel J. Rusk(Executive Officer, Director)Christopher R. Fernandez(Executive Officer, Director)inJustin Mortara(Executive Officer, Director)inMatthew D Dobereiner(Executive Officer)
Board seatMark Bakken· per SEC Form D
Co-investorsColle Capital Partnersgener8torGreat North VenturesNecessary VenturesQuesta CapitalSupermoon Capital+1 more
Milwaukee, US
Paul Auer(Director)Brittany Gottschalk(Executive Officer, Director)
BoardLaura Hilty(Director)in
Board seatMark Bakken· per SEC Form D · $3.3M raise · filed Oct 2022
Co-investorsExcelerate Health Ventures
HealthtechMadison, US
James A Dias(Executive Officer, Director)Abraham W. Palmbach(Executive Officer, Director)Abraham W Palmbach(Executive Officer, Director)
BoardGregory J Baldwin(Director)
Board seatMark Bakken· per SEC Form D · $2.2M raise · filed Nov 2022
HealthtechChantilly, US
Olivia Walch(Executive Officer, Director)Daniel Forger(Executive Officer, Director)
BoardMichael Masterson(Director)in
Co-investorsSupermoon CapitalInflect Health
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.